Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.

Allain H, Bentué-Ferrer D, Breton SL, Polard E, Gandon JM.

Hum Psychopharmacol. 2003 Jul;18(5):369-74.

PMID:
12858323
3.

Effects of nicardipine and clonidine on cognitive functions and electroencephalography in hypertensive patients.

Denolle T, Sassano P, Allain H, Bentué-Ferrer D, Breton S, Cimarosti I, Ouatara B, Merienne M, Gandon JM.

Fundam Clin Pharmacol. 2002 Dec;16(6):527-35.

PMID:
12685512
4.

Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects.

Patat A, Rosenzweig P, Enslen M, Trocherie S, Miget N, Bozon MC, Allain H, Gandon JM.

Hum Psychopharmacol. 2000 Apr;15(3):153-170.

PMID:
12404329
6.

Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers.

Schück S, Bentué-Ferrer D, Kleinermans D, Reymann JM, Polard E, Gandon JM, Allain H.

Fundam Clin Pharmacol. 2002 Feb;16(1):57-65.

PMID:
11903513
7.

Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep-deprived subjects.

Patat A, Rosenzweig P, Miget N, Allain H, Gandon JM.

Fundam Clin Pharmacol. 1999;13(5):582-94.

PMID:
10520732
8.

Effects of tiapride on electroencephalograms and cognitive functions in the elderly.

Patat A, Alberini H, Bonhomme D, Soubrane C, Allain H, Gandon JM.

Int Clin Psychopharmacol. 1999 Jul;14(4):199-208.

PMID:
10468312
9.

Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer's disease.

Allain H, Schück S, Lebreton S, Strenge-Hesse A, Braun W, Gandon JM, Brissot P.

Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):181-5.

PMID:
10325444
10.

Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor.

Rosenzweig P, Patat A, Zieleniuk I, Cimarosti I, Allain H, Gandon JM.

Clin Pharmacol Ther. 1998 Aug;64(2):211-22.

PMID:
9728902
11.

Effect of bromazepam versus placebo on inhibition and waiting capacity in young women with traits of anxiety.

Schuck S, Allain H, Gandon JM, Patat A, Millet V, Le Coz F.

Fundam Clin Pharmacol. 1998;12(4):463-7.

PMID:
9711471
12.

Antidepressant-like effects of alnespirone (S 20499) in the learned helplessness test in rats.

Mac Sweeney CP, Lesourd M, Gandon JM.

Eur J Pharmacol. 1998 Mar 19;345(2):133-7.

PMID:
9600628
13.

Absolute bioavailability and electroencephalographic effects of conventional and extended-release formulations of venlafaxine in healthy subjects.

Patat A, Troy S, Burke J, Trocherie S, Danjou P, Le Coz F, Allain H, Gandon JM.

J Clin Pharmacol. 1998 Mar;38(3):256-67.

PMID:
9549664
14.

[Baseline blood pressure in healthy normotensive volunteers].

Denolle T, Albérini H, Turbin A, Cimarosti I, Patat A, Gandon JM.

Arch Mal Coeur Vaiss. 1997 Aug;90(8):1097-101. French.

PMID:
9404416
15.

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.

Edan G, Miller D, Clanet M, Confavreux C, Lyon-Caen O, Lubetzki C, Brochet B, Berry I, Rolland Y, Froment JC, Cabanis E, Iba-Zizen MT, Gandon JM, Lai HM, Moseley I, Sabouraud O.

J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):112-8.

16.

Drugs used in Alzheimer's disease and neuroplasticity.

Allain H, Bentue-Ferrer D, Gandon JM, Le Doze F, Belliard S.

Clin Ther. 1997 Jan-Feb;19(1):4-15; discussion 2-3. Review.

PMID:
9083704
17.

Bridging study of S12024 in 53 in-patients with Alzheimer's disease.

Allain H, Neuman E, Malbezin M, Salzman V, Guez D, Wesnes K, Gandon JM.

J Am Geriatr Soc. 1997 Jan;45(1):125-6. No abstract available.

PMID:
8994509
18.

Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.

Bellissant E, Denolle T, Sinnassamy P, Bichet DG, Giudicelli JF, Lecoz F, Gandon JM, Allain H.

J Pharmacol Exp Ther. 1996 Jul;278(1):232-42.

PMID:
8764356
19.

[Randomized double-blind comparative study of minaprine (200mg/j) and of placebo on memory loss].

Allain H, Belliard S, Lieury A, Menard G, Patat A, Le Coz F, Gandon JM.

Therapie. 1996 Mar-Apr;51(2):155-62. French.

PMID:
8763050
20.

[Study of correlations between self-estimation of memory, psychometric test (SM9) and test of memory in daily life].

Lieury A, Germain R, Menard G, Gandon JM, Allain H.

Therapie. 1996 Mar-Apr;51(2):131-8. French.

PMID:
8763047
21.

Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteers.

Patat A, le Coz F, Dubruc C, Gandon JM, Durrieu G, Cimarosti I, Jezequel S, Curet O, Zieleniuk I, Allain H, Rosenzweig P.

J Clin Pharmacol. 1996 Mar;36(3):216-29.

PMID:
8690815
22.

Procedural memory and Parkinson's disease.

Allain H, Lieury A, Quemener V, Thomas V, Reymann JM, Gandon JM.

Dementia. 1995 May-Jun;6(3):174-8.

PMID:
7620531
23.

Explicit and procedural memory in Parkinson's disease.

Allain H, Lieury A, Thomas V, Reymann JM, Gandon JM, Belliard S.

Biomed Pharmacother. 1995;49(4):179-86.

PMID:
7669937
24.

Monoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases.

Delumeau JC, Bentué-Ferrer D, Gandon JM, Amrein R, Belliard S, Allain H.

J Neural Transm Suppl. 1994;41:259-66. Review.

PMID:
7931235
25.

Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects.

Allain H, Raoul P, Lieury A, LeCoz F, Gandon JM, d'Arbigny P.

Clin Ther. 1993 May-Jun;15(3):549-58.

PMID:
8364946
26.

Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline.

Allain H, Lieury A, Brunet-Bourgin F, Mirabaud C, Trebon P, Le Coz F, Gandon JM.

Psychopharmacology (Berl). 1992;106 Suppl:S56-61.

PMID:
1546142
27.

Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover study.

Allain H, Le Coz F, Goulley F, Brunet-Bourgin F, Loria Y, Bentue-Ferrer D, Decombe R, Reymann JM, Chaumet-Riffaud P, Gandon JM.

Int J Clin Pharmacol Ther Toxicol. 1991 Aug;29(8):314-22.

PMID:
1743806
28.

[Development of memory-improving drugs].

Allain H, Lieury A, Reymann JM, Martinet JP, Trebon P, Decombe R, Bentue-Ferrer D, Gandon JM.

Ann Med Interne (Paris). 1990;141 Suppl 1:19-25. Review. French.

PMID:
1964542
29.

[Experimental verification of the favorable activity of synthetic corticostimulin on brain edema induced by ischemia in rats].

Gandon JM, Bagot H, Bentue-Ferrer D, Allain H, de Certaines JD.

Presse Med. 1989 Mar 25;18(12):625-7. French.

PMID:
2524731

Supplemental Content

Loading ...
Support Center